MiNK Therapeutics Announces Publication of Complete Remission Following Allogeneic iNKT Cell Therapy in Metastatic Testicular Cancer
NEW YORK, July 11, 2025 (GLOBE NEWSWIRE) -- MiNK Therapeutics, Inc. (NASDAQ: INKT), a clinical-stage biopharmaceutical company pioneering allogeneic, off-the-shelf invariant natural killer T (iNKT) cell therapies, today announced the publication of another landmark case in Nature's Oncogene describing a complete and durable remission in a patient with metastatic, treatment-refractory testicular cancer, following treatment with agenT-797, MiNK's allogeneic iNKT cell therapy.
Complete remission after failure on platinum-based chemotherapy, autologous stem cell transplant, and multiple ICIs (anti–PD-1, anti–CTLA-4, and anti–TIGIT)
The publication, titled 'Salvage therapy with allogeneic invariant natural killer T cells in a heavily pre-treated germ cell tumor,' presents a patient case from MiNK's clinical trial (NCT05108623). The patient had progressed after multiple lines of therapy—including platinum-based chemotherapy, autologous stem cell transplant, and multiple immune checkpoint inhibitors (anti–PD-1, anti–CTLA-4, and anti–TIGIT)—and received a single infusion of agenT-797 alongside nivolumab. The patient achieved a complete clinical, radiologic, and biochemical remission, with no evidence of disease over two years later. Donor iNKT cells were detectable up to six months post-infusion, and treatment was well-tolerated with no cytokine release syndrome (CRS) or graft-versus-host disease (GVHD).
'This case exemplifies the powerful potential of iNKT cells in treating even the most challenging cancers,' said Dr. Benjamin Garmezy, Assistant Director of Genitourinary Research for Sarah Cannon Research Institute at SCRI Oncology Partners. 'We observed a remarkable response in a patient who had exhausted standard and experimental treatments, offering compelling evidence to further pursue clinical studies of iNKT cell therapies in solid tumors.'
Durable Responses & Immune Activation in Solid Tumors with Allo-iNKT Therapy
These findings are part of a growing body of clinical evidence supporting the potential of agenT-797 in solid tumors. At the 2025 inaugural AACR Immuno-Oncology meeting, MiNK presented data from its Phase 2 trial in 2L gastric cancer, demonstrating immune activation, increased tumor infiltration, and early signals of tumor control in patients previously refractory to checkpoint inhibitors. Notably, extended survival beyond 12 months was observed in several patients—an outcome rarely seen in this setting. These clinical observations were further reinforced in a separate peer-reviewed case report published in Oncogene, which described a patient with metastatic gastric cancer who achieved a 42% tumor reduction and more than nine months of progression-free survival following a single infusion of agenT-797 in combination with nivolumab.
Together, these data highlight the potential of agenT-797 to reshape the tumor microenvironment and deliver durable clinical activity, even in heavily pretreated, immunotherapy-resistant cancers. The ongoing Phase 2 trial in gastric cancer (NCT06251973) is actively enrolling, with additional readouts expected in upcoming months. You can access the full publication here.
About MiNK Therapeutics
MiNK Therapeutics is a clinical-stage biopharmaceutical company advancing a new class of allogeneic invariant natural killer T (iNKT) cell therapies and precision-targeted immune technologies. MiNK's proprietary platform is designed to restore immune balance and drive cytotoxic responses across cancer, immune-mediated diseases, and pulmonary immune failure. The company's lead candidate, agenT-797, is an off-the-shelf, cryopreserved iNKT cell therapy currently in clinical development for graft-versus-host disease (GvHD), solid tumors, and severe pulmonary inflammation. MiNK is also advancing a pipeline of T cell receptor (TCR)-based therapies and neoantigen discovery tools that enable highly specific immune targeting across tumor and tissue types. With a scalable manufacturing process and a differentiated mechanism that bridges innate and adaptive immunity, MiNK is committed to delivering accessible, durable, and broadly applicable immune reconstitution therapies. For more information, visit www.minktherapeutics.com or follow us on X @MiNK_iNKT. Information important to investors is routinely posted to our website and social media channels.
About AgenT-797
AgenT-797 is an allogeneic invariant natural killer T (iNKT) cell therapy that harnesses the dual power of innate and adaptive immunity. iNKTs function as 'master regulators,' combining the cytotoxic capabilities of NK cells with T-cell–like antigen recognition and memory. This unique biology enables a robust, pathogen-agnostic immune response that can be directed against hard-to-treat tumors.
Manufactured by MiNK Therapeutics in Lexington, MA, agenT-797 is a scalable, off-the-shelf product designed to provide accessible, transformative treatment options. In clinical trials, agenT-797 can bolster peripheral memory T-cell activation, enhance tumor infiltration, and potentially improve outcomes for patients with solid cancers (Cytryn et al., AACR IO 2024; Oncogene, 2024), as well as reduce inflammation in critically ill patients with severe respiratory pathology (Nature Communications, 2024).
Forward Looking Statements
This press release contains forward-looking statements that are made pursuant to the safe harbor provisions of the federal securities laws, including statements regarding the therapeutic potential, anticipated benefit, plans and timelines of iNKT cells. These forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially. These forward-looking statements are subject to risks and uncertainties, including the factors described under the Risk Factors section of the most recent Form 10-K, Form 10-Q and the S-1 Registration Statement filed with the SEC. MiNK cautions investors not to place considerable reliance on the forward-looking statements contained in this release. These statements speak only as of the date of this press release, and MiNK and Agenus with no obligation to update or revise the statements, other than to the extent required by law. All forward-looking statements are expressly qualified in their entirety by this cautionary statement.
CONTACT: Investor Contact 917-362-1370 investor@minktherapeutics.com Media Contact 781-674-4428 communications@minktherapeutics.com
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
16 minutes ago
- Yahoo
Verizon And Federal Wins Power Ribbon Communications' Confident Outlook
Ribbon Communications (NASDAQ:RBBN) reported a robust second quarter for 2025, driven by strong demand and key customer wins. Ribbon Communications reported total second-quarter 2025 revenue of $221 million, marking a 22% sequential increase and a 15% year-over-year rise, surpassing estimates by approximately $6 million. This growth was fueled by strong performance with major clients, including Verizon Communications (NYSE:VZ) and U.S. federal agencies, and the successful closure of several previously delayed deals. Despite some pressure on gross margins due to a mix of hardware and professional services sales, the company's Cloud and Edge segment delivered record-high profitability, and its IP Optical segment saw a significant improvement in its financial performance. Ribbon Communications also maintained its full-year outlook, forecasting continued growth and the earnings report, Rosenblatt analyst Mike Genovese reaffirmed a Buy rating for Ribbon Communications and increased his price forecast from $5.50 to $6.00. This positive adjustment came despite a slight dip in the stock's trading price on the day of the announcement. Genovese highlighted that the impressive revenue growth was driven by continued strong demand from Verizon Communications, U.S. federal agencies, new wins in critical infrastructure, and Bharti Airtel in India. He said the company also secured a new contract with a Tier 1 telecom operator in Southeast Asia, while several previously delayed deals closed during the quarter. Domestic revenue reached $117 million, jumping 40% quarter-over-quarter and 45% year-over-year. International revenue came in at $104 million, rising 6% sequentially but declining 7% compared to the prior year. Genovese noted that the Cloud and Edge segment delivered $137 million in revenue, up 27% sequentially and 24% year-over-year, which was in line with expectations driven by robust growth from Verizon and government customers. He pointed out that Verizon accounted for 20% of Ribbon's total revenue and was the only customer exceeding 10% of sales, as it continues to modernize its voice network. Cloud and Edge gross margins contracted 110 basis points sequentially and 410 basis points year-over-year to 61.9%, largely due to a higher mix of professional services and hardware and a dip in maintenance and software sales. Despite the margin pressure, Genovese pointed out that the segment posted a record adjusted EBITDA of $37 million. The analyst said IP Optical revenue rose to $84 million, up 13% sequentially and 2% year-over-year, beating estimates by 6%. Sales in India and North America surged over 40% year-over-year. Excluding Eastern Europe, the IP Optical segment posted a 5% annual increase. He noted that the segment's gross margin expanded 760 basis points sequentially to 35.9%, supported by stronger North American sales, improved mix and margins in Asia-Pacific, and better fixed cost absorption from higher volume. The adjusted EBITDA loss for IP Optical narrowed to $5 million from a $15 million loss a year ago. Company-wide gross margin reached 52.1%, expanding 340 basis points quarter-over-quarter, though contracting 230 basis points year-over-year, missing estimates due to a greater share of hardware and services revenue, Genovese noted. The analyst said that operating margin expanded sharply to 12.5%, up 1,120 basis points sequentially and 300 basis points year-over-year, beating projections by 20 basis points. He noted that adjusted EBITDA totaled $32 million, representing a 433% increase sequentially and 47% growth year-over-year, at the high end of company guidance. Genovese noted that management guided third-quarter revenue between $213 million and $227 million, slightly below prior estimates. The analyst expects IP Optical revenue to grow sequentially, while Cloud and Edge revenue will likely decline, primarily due to project timing with Verizon. Gross margins are projected between 53.5% and 54%, below the prior 55.9% estimate, and adjusted EBITDA is forecast between $28 million and $34 million. The company reiterated its full-year 2025 outlook, maintaining revenue guidance of $870 million to $890 million, gross margins of 54%–55%, and adjusted EBITDA of $130 million to $140 million. However, management noted that GMs and EBITDA are trending toward the lower end of those ranges due to stronger-than-expected product and professional services sales and a $2 million quarterly opex impact from the weaker U.S. dollar. Genovese noted that management expects the fourth quarter to remain the strongest quarter of the year, as is typical for Ribbon. Additionally, the firm anticipates $15 million to $20 million in tax savings following a recent bill passed by Congress. Genovese highlighted that the Ribbon story remains attractive, especially at a valuation of 12.5x estimated 2026 EPS. The analyst emphasized Ribbon's ability to weather recent headwinds, such as its exit from Eastern Europe and timing-related delays in the Federal and Enterprise sectors, while consistently delivering on its guidance across multiple quarters. He also noted meaningful improvement in the Cloud and Edge narrative, particularly with Verizon's shift to next-gen voice infrastructure, enhancing Ribbon's growth prospects. Additionally, Genovese noted that Ribbon could win a similar deal with AT&T (NYSE:T), which has committed to fully modernizing its voice systems by 2029. He highlighted growing synergies between Ribbon's business segments, as Verizon now uses its routers for the Cloud and Edge upgrade, a signal of broader strategic alignment and opportunity ahead. Price Action: RBBN stock is trading lower by 11.7% to $3.76 at last check Thursday. Latest Ratings for RBBN Date Firm Action From To Jan 2021 B. Riley Securities Initiates Coverage On Buy Oct 2019 Northland Capital Markets Downgrades Outperform Market Perform Aug 2018 Cowen & Co. Upgrades Underperform Market Perform View More Analyst Ratings for RBBN View the Latest Analyst Ratings Up Next: Transform your trading with Benzinga Edge's one-of-a-kind market trade ideas and tools. Click now to access unique insights that can set you ahead in today's competitive market. Get the latest stock analysis from Benzinga? This article Verizon And Federal Wins Power Ribbon Communications' Confident Outlook originally appeared on © 2025 Benzinga does not provide investment advice. All rights reserved.
Yahoo
16 minutes ago
- Yahoo
New data from Global Water Intelligence reveals impact of hyperscale data center boom on onsite water consumption and unprecedented growth in water technology and infrastructure spending
OXFORD, United Kingdom, July 24, 2025 (GLOBE NEWSWIRE) -- New research from GWI has found that onsite water consumption for data center cooling is forecast to increase by just over 50% by 2030, despite data center capacity doubling over the same findings reflect significant efficiency gains in water use, with a shift to water-efficient cooling technologies. These technologies require higher quality water, and GWI therefore predicts that these strides in responsible water use will be supported by unprecedented double digit annual growth in water-related technology and infrastructure spending for data centers. Hybrid air-water cooling, as well systems designed for AI workloads, where chips are in direct contact with a water-based coolant, are increasingly the norm for data centers. Additionally there is a shift to lower-quality recycled water as the sector cuts its freshwater use. However, the extent of these efficiency gains is not globally balanced, nor are they always related to concerns of water stress. In India, for example, data center water use is set to more than double by 2030, posing major risks in a country already facing extreme water stress. Data centers can reduce their onsite water footprint by switching to dry cooling, but this drives up energy use, leading to greater indirect water consumption from power generation. As power demand continues to surge through 2030 and beyond, water-efficient cooling will be essential to the sustainable growth of data centers. Access the full dataset via our rich forecast data dashboard. Book a demo directly at For general inquiries contact: sales@ About Global Water Intelligence Global Water Intelligence (GWI) is the leading market intelligence and events company serving the international water industry. Over the last 25 years we have built our business around being a trusted interface between our clients and their markets, providing our customers with high-level intelligence that enables them to make the most informed strategic decisions for their business. We cover municipal markets and every industrial vertical as well as technology, finance and economics. GWI runs an advanced manufacturing conference focusing on semiconductors and data centers: CONTACT: Victor SmithCOMPANY: Global Water IntelligencePHONE: 01865 204208 EMAIL: sales@ A photo accompanying this announcement is available at
Yahoo
16 minutes ago
- Yahoo
Flutter announces the pricing of $1,272 million aggregate principal amount of Additional Senior Secured Notes due 2031
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION,DIRECTLY OR INDIRECTLY, IN ANY JURISDICTION WHERE IT IS UNLAWFUL TO DO SO DUBLIN and TORONTO, July 24, 2025 (GLOBE NEWSWIRE) -- Flutter Entertainment plc ('Flutter') (NYSE:FLUT; LSE:FLTR), today announced the pricing of an offering (the 'Offering') of $625 million aggregate principal amount of 5.875% senior secured notes due 2031 issued at par, €300 million aggregate principal amount of 4.000% senior secured notes due 2031 issued at par, and £250 million aggregate principal amount of 6.125% senior secured notes due 2031 issued at 100.125% (collectively, the 'Notes') by its subsidiary Flutter Treasury DAC (the 'Issuer'). The Notes will constitute a further issuance of the Issuer's 5.875% senior secured notes due 2031, 4.000% senior secured notes due 2031 and 6.125% senior secured notes due 2031 that were each issued on June 4, 2025. An application will be made for the Notes to be admitted to trading on The International Stock Exchange. The Offering is subject to customary closing conditions, and settlement is expected to occur on or around August 7, 2025. Flutter today also announced that it has priced its new U.S. dollar-denominated term loan B facility (the 'Fourth Incremental TLB Facility'). The proceeds from the Offering and the Fourth Incremental TLB Facility are expected to be utilized to fund the purchase price for the acquisition of the outstanding 5% minority interest in FanDuel and the extension of our long-term strategic partnership with Boyd Interactive Gaming Holdings, L.L.C.. The Issuer expects to utilize cash on balance sheet to pay certain costs, fees and expenses incurred in connection with the foregoing transactions. About Flutter Entertainment plc Flutter is the world's leading online sports betting and iGaming operator, with a market leading position in the US and across the world. Our ambition is to leverage our significant scale and our challenger mindset to change our industry for the better. By Changing the Game, we believe we can deliver long-term growth while promoting a positive, sustainable future for all our stakeholders. We are well-placed to do so through the distinctive, global competitive advantages of the Flutter Edge, which gives our brands access to group-wide benefits to stay ahead of the competition, as well as our clear vision for sustainability through our Positive Impact Plan. Flutter operates a diverse portfolio of leading online sports betting and iGaming brands including FanDuel, Sky Betting & Gaming, Sportsbet, PokerStars, Paddy Power, Sisal, Snai, tombola, Betfair, MaxBet, Junglee Games, Adjarabet and Betnacional. To learn more about Flutter, please visit our website at EnquiriesInvestor Relations: Relations: corporatecomms@ Cautionary Statement The Notes will be offered only to qualified institutional buyers pursuant to Rule 144A and to non-U.S. persons outside the United States pursuant to Regulation S under the U.S. Securities Act of 1933, as amended (the 'Securities Act'), subject to prevailing market and other conditions. There is no assurance that the offering will be completed or, if completed, as to the terms on which it is completed. This press release is not an offer to sell the Notes in the United States or in any other jurisdiction and is issued pursuant to Rule 135c under the Securities Act of 1933. The Notes to be offered have not been and will not be registered under the Securities Act or the securities laws of any other jurisdiction and may not be offered or sold, directly or indirectly, in the United States or to or for the account or benefit of U.S. persons, as such term is defined in Regulation S of the Securities Act, absent registration or unless pursuant to an applicable exemption from the registration requirements of the Securities Act and any other applicable securities laws. If any public offering of the Notes is made in the United States, it will be by means of a prospectus that may be obtained from the Issuer that will contain detailed information about the Issuer, Flutter and management, as well as financial statements. No public offering of the Notes will be made in the United States in connection with the above-mentioned transaction. This press release has been prepared on the basis that any offer of the Notes in any member state of the European Economic Area ('EEA') will be made pursuant to an exemption under Regulation (EU) 2017/1129, as amended (the 'Prospectus Regulation') from the requirement to publish a prospectus for offers of notes. This press release has been prepared on the basis that any offer of the Notes in the United Kingdom will be made pursuant to an exemption under the Prospectus Regulation, as it forms part of domestic law by virtue of the European Union (Withdrawal) Act 2018 (the 'UK Prospectus Regulation') and the Financial Services and Markets Act 2000 from the requirement to publish a prospectus for offers of notes. The Notes are not intended to be offered, sold or otherwise made available to and should not be offered, sold or otherwise made available to any retail investor in the EEA. For these purposes, a retail investor means a person who is one (or more) of: (i) a retail client as defined in point (11) of Article 4(1) of Directive 2014/65/EU (as amended, 'MiFID II'); (ii) a customer within the meaning of Directive (EU) 2016/97 (as amended), where that customer would not qualify as a professional client as defined in point (10) of Article 4(1) of MiFID II, or (iii) not a qualified investor as defined in the Prospectus Regulation. Consequently, no key information document required by Regulation (EU) No 1286/2014 (as amended, the 'PRIIPs Regulation') for offering or selling the Notes or otherwise making them available to retail investors in the EEA has been prepared and therefore offering or selling the Notes or otherwise making them available to any retail investor in the EEA may be unlawful under the PRIIPs Regulation. This press release does not constitute and shall not, in any circumstances, constitute an offering to retail investors. The offer and sale of the Notes in any member state of the EEA will be made pursuant to an exemption under the Prospectus Regulation from the requirement to publish a prospectus for offers of notes. The preliminary offering memorandum produced for the offering of the Notes is not a prospectus for the purposes of the Prospectus Regulation. This press release does not constitute an offer of securities to the public in the United Kingdom. In the United Kingdom, this press release is being distributed only to, and is directed only at persons who are 'qualified investors' (as defined in the UK Prospectus Regulation) who are (i) persons having professional experience in matters relating to investments falling within Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (as amended, the 'Order'), (ii) high net worth entities falling within Article 49(2)(a) to (d) of the Order, or (iii) persons to whom it would otherwise be lawful to distribute it, all such persons together being referred to as 'Relevant Persons.' In the United Kingdom, the preliminary offering memorandum produced for the offering of the Notes and this press release are being distributed only to and directed only at Relevant Persons and must not be acted on or relied upon by persons who are not Relevant Persons. In the United Kingdom, any investment or investment activity to which this document relates is available only to Relevant Persons and will be engaged in only with Relevant Persons. In the United Kingdom, the Notes are only available to, and any invitation, offer or agreement to subscribe, purchase or otherwise acquire such Notes will be engaged in only with, Relevant Persons, as the preliminary offering memorandum produced for the offering of the Notes and its contents are confidential and should not be distributed, published or reproduced (in whole or in part) or disclosed by any recipients to any other person. Any person in the United Kingdom that is not a Relevant Person should not act or rely on the preliminary offering memorandum produced for the offering of the Notes or this press release or its contents. The Notes described in the preliminary offering memorandum are not being offered to the public in the United Kingdom. MiFID II professionals / ECPs-only / No PRIIPs KID – Manufacturer target market (MIFID II product governance) is eligible counterparties and professional clients only (all distribution channels). No PRIIPs key information document (KID) has been prepared as not available to retail investors in the EEA or the United Kingdom. Forward-Looking Statements This press release may include forward-looking statements. These forward looking statements can be identified by the use of forward looking terminology, including the terms 'outlook,' 'believe(s),'expect(s),' 'potential,' 'continue(s),' 'may,' 'will,' 'should,' 'could,' 'would,' 'seek(s),' 'predict(s),' 'intend(s),' 'trends,' 'plan(s),' 'estimate(s),' 'anticipates,' 'projection,' 'goal,' 'target,' 'aspire,' 'will likely result' and other words and terms of similar meaning or the negative versions of such words or other comparable words of a future or forward-looking nature. These forward-looking statements include all matters that are not historical facts and include statements regarding Flutter's or its affiliates' intentions, beliefs or current expectations concerning, among other things, Flutter's or its affiliates' results of operations, financial condition, liquidity, prospects, growth, strategies and the industries in which they operate. By their nature, forward-looking statements involve risks and uncertainties because they relate to events and depend on circumstances that may or may not occur in the future. Readers are cautioned that forward-looking statements are not guarantees of future performance and that Flutter's or its affiliates' actual results of operations, financial condition and liquidity, and the development of the industries in which they operate may differ materially from those made in or suggested by the forward-looking statements contained in this press release. In addition, even if Flutter's or its affiliates' results of operations, financial condition and liquidity, and the development of the industries in which they operate are consistent with the forward-looking statements contained in this press release, those results or developments may not be indicative of results or developments in subsequent periods. This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@ or visit in to access your portfolio
